Synucleinopathies in humans—including Parkinson’s disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy (MSA)—are essentially characterized by the misfolding/aggregation of the alpha-synuclein (aS) protein within intracellular lesions in neurons (PD and DLB) and/or glial cells (MSA). Here, SNCA is linked to multiple system atrophy.